UnknownNot Applicable

Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute

2 participantsStarted 2023-11-01

Plain-language summary

Cancer is the second most frequent cause of premature death in children. The incidence of pediatric cancer varies by region and country, but it is generally considered rare with an estimated 300,000 new cases diagnosed worldwide. Acute kidney injury in pediatric cancer patients refers to the sudden and often temporary loss of renal function, which can lead to a variety of complications if not treated correctly.

Who can participate

Age range30 Days – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Children of both sexes (aged from 1 month to 18 years at diagnosis) * Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department Exclusion Criteria: * Children who had an unconfirmed cancer diagnosis. * Children more than 18 years at diagnosis. * Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month * The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level. * Patient underwent renal transplant.

What they're measuring

To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)

Timeframe: from November 2023 till November 2024

Trial details

NCT IDNCT06081608

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI) trials